Terminology: Difference between revisions

From NCPeH CY
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
In this page all the terms used to describe the health in the [[Patient Profile|Patient Profile]] screen are presented. Below each term in [[Terminology#Ranges|Ranges]] and [[Terminology#Scores|Scores]] sections you can find links to the locations of the Patient Profile wiki page where the corresponding terms are used. By clicking these links you will be driven to the corresponding parameter's section in the [[Patient Profile|Patient Profile]] page of this wiki.
= Acronyms Finder=
= Acronyms Finder=


Line 5: Line 7:
!style="text-align:left;"| [[Terminology#Vital Signs|Vital Signs]]
!style="text-align:left;"| [[Terminology#Vital Signs|Vital Signs]]
!
!
!
!style="text-align:left;"|Social history
|-
|style="vertical-align:top;"|<table cellspacing=0 cellpadding=0><tr><td valign=top>[https://medical-dictionary.thefreedictionary.com/temperature Temperature (°C)]<br>[https://medical-dictionary.thefreedictionary.com/heart+rate Heart Rate (bpm)] <br> [https://medical-dictionary.thefreedictionary.com/systolic+pressure Systolic Pressure (mm Hg)] <br>[https://medical-dictionary.thefreedictionary.com/diastolic+pressure Diastolic Pressure (mm Hg)]<br> [https://medical-dictionary.thefreedictionary.com/respiratory+rate Respiratory Rate (bpm)]
<br>[https://medical-dictionary.thefreedictionary.com/SpO2 SpO2 (%)]<br>  </table>
|style="width:9%"|
| style="vertical-align:top;"|<table cellspacing=0 cellpadding=0><tr><td valign=top>[https://medical-dictionary.thefreedictionary.com/ph pH]<br>[https://www.ncbi.nlm.nih.gov/pubmed/17573487 <span style="color:ForestGreen">SpO2 </span>]</table>
|style="width: 7%"|                                                           
| style="vertical-align:top;"|<table cellspacing=0 cellpadding=0><tr><td valign=top>Covi<td>d-19 Related<br>[https://medical-dictionary.thefreedictionary.com/hs-CRP hs-CRP ((mg/L))]<br>
|style="width: 5%"|                                                           
| style="vertical-align:top;"|<table cellspacing=0 cellpadding=0><tr><td valign=top> Alcohol intake<br>Health-related behavior <br> Tobacco use and exposure <br> Exercise <br> Details of drug misuse behavior <br> Nutritional observable <br> Employment detail <br> Toxic exposure status</table>
|}
{|style = "width:100%"
|- style="vertical-align:top;"
!style="text-align:left;"|Comorbidities
!
!style="text-align:left;"|Symptoms
!
!
!
!
!style="text-align:left;"|Social history
!style="text-align:left;"|<span id="Ventilation_Treatment">Ventilation Treatment</span>
|-
|style="vertical-align:top; width:153px;"|<table cellspacing=0 cellpadding=0><tr><td valign=top>[https://medical-dictionary.thefreedictionary.com/hypertension Hypertension]<br>[https://medical-dictionary.thefreedictionary.com/diabetes Diabetes] <br> [https://medical-dictionary.thefreedictionary.com/cardiovascular+disease Cardiovascular disease] <br>[https://medical-dictionary.thefreedictionary.com/liver+disease Liver disease]<br> [https://medical-dictionary.thefreedictionary.com/nervous+system+disease Nervous system disease] <br>[https://medical-dictionary.thefreedictionary.com/Chronic+obstructive+pulmonary+disease Chronic respiratory/ lung disease]<br> [https://medical-dictionary.thefreedictionary.com/chronic+kidney+disease Chronic kidney disease] <br>[https://encyclopedia.thefreedictionary.com/endocrine+disease Endocrine system disease]<br> [https://www.thefreedictionary.com/blood+disorder Hematologic disease] <br>  [https://medical-dictionary.thefreedictionary.com/tumor Tumor]<br> [https://medical-dictionary.thefreedictionary.com/immunosuppression Immunosuppression] <br> [https://medical-dictionary.thefreedictionary.com/Immunodeficiency Immunodeficiency]</table>
|style="width:66px;"|                                                           
|style="vertical-align:top; width:115px;"|<table cellspacing=0 cellpadding=0><tr><td valign=top>Cons<td>titutional<br>[https://medical-dictionary.thefreedictionary.com/fever Fever] <br> [https://medical-dictionary.thefreedictionary.com/myalgia Myalgia] <br>[https://medical-dictionary.thefreedictionary.com/headache Headache]</table>
<table cellspacing=0 cellpadding=0> <tr><td valign=top> Uppe<td>r&#160;Respiratory<br>[https://medical-dictionary.thefreedictionary.com/Rhinorrhea Rhinorrhea] <br>[https://encyclopedia.thefreedictionary.com/Nasal+Congestion Nasal Congestion] <br> [https://medical-dictionary.thefreedictionary.com/Sore+throat Sore throat]</table>
<table cellspacing=0 cellpadding=0> <tr><td valign=top> Lowe<td>r&#160;Respiratory<br>[https://medical-dictionary.thefreedictionary.com/Dyspnea Dyspnea] <br>[https://medical-dictionary.thefreedictionary.com/chest+pain Chest tightness] <br> [https://medical-dictionary.thefreedictionary.com/cough Cough] <br> [https://medical-dictionary.thefreedictionary.com/Sputum Sputum]</table>
|style="width: 50px"|                                                           
| style="vertical-align:top; width:173px;"|<table cellspacing=0 cellpadding=0> <tr><td valign=top> Gast<td>rointestinal<br>[https://medical-dictionary.thefreedictionary.com/Nausea Nausea] <br>[https://medical-dictionary.thefreedictionary.com/Diarrhea Diarrhea] </table>
<table cellspacing=0 cellpadding=0> <tr><td valign=top> Neur<td>ological<br>[https://medical-dictionary.thefreedictionary.com/ageusia Ageusia] <br>[https://medical-dictionary.thefreedictionary.com/Anosmia Anosmia] <br>[https://medical-dictionary.thefreedictionary.com/Communication+disorder Communication disorder] <br> [https://medical-dictionary.thefreedictionary.com/Confusion Acquired Confusion]<br>[https://medical-dictionary.thefreedictionary.com/Lethargy Lethargy]</table>
|style="width: 35px;"|                                                           
</table>
 
|}
 
=Ranges=
== Vital Signs==
[https://medical-dictionary.thefreedictionary.com/vital+signs Definition]
 
{| class="wikitable"
|+Vital Signs
! style="text-align: center; " | Type
! style="text-align: center; " | Ranges
|-
| [https://medical-dictionary.thefreedictionary.com/temperature Temperature (°C)]
| 36.1 -37.2 (°C)
|-
| [https://medical-dictionary.thefreedictionary.com/heart+rate Heart Rate (bpm)]
| 60-100 (bpm)
|-
| [https://medical-dictionary.thefreedictionary.com/systolic+pressure Systolic Pressure (mm Hg)]
| 90-140  (mm Hg)
|-
| [https://medical-dictionary.thefreedictionary.com/diastolic+pressure Diastolic Pressure (mm Hg)]
| 75-90  (mm Hg)
|-
| [https://medical-dictionary.thefreedictionary.com/respiratory+rate Respiratory Rate (bpm)]
| 16-20 (bpm)
|-
| [https://medical-dictionary.thefreedictionary.com/SpO2 SpO2 (%)]
| >93%
|-
| [https://medical-dictionary.thefreedictionary.com/urine Urine Output (ml/kg/h)]
| Based on Fluid Balance (Intake/ Output)
|}
 
Find it in Patient Profile wiki page: [[(Patient_Profile)_Demographics_%26_Status#Add_Vital_Signs_.28Mews.29|[Demographics & Status]]], [[(Patient_Profile)_Patient_Summary#Monitoring_Charts|[Monitoring Charts]]], [[(Patient_Profile)_EHR_-_Daily_Monitoring#Vital_Signs|[Daily Monitoring]]]
 
== Arterial Blood Gases (ABG)==
[https://medical-dictionary.thefreedictionary.com/Arterial+Blood+Gas Definition]
 
An arterial blood gases (ABG) test measures the acidity (pH) and the levels of oxygen and carbon dioxide in the blood from an artery. This test is used to check how well your lungs are able to move oxygen into the blood and remove carbon dioxide from the blood.
 
{| class="wikitable"
|+ Arterial Blood Gases
! style="text-align: center;" | Type
! style="text-align: center;" | Ranges
|-
| [https://medical-dictionary.thefreedictionary.com/ph pH]
| 7.35 - 7.45
|-
| [https://medical-dictionary.thefreedictionary.com/HCO3 HCO3 (mEq/L)]
| 22 - 26 (mEq/L)
|-
| [https://medical-dictionary.thefreedictionary.com/PaCO2 PaCO2(mmHg)]
| 35 - 45 (mmHg)
|-
| [https://medical-dictionary.thefreedictionary.com/PaO2 PaO2 (mmHg)]
| 75 - 100 (mmHg)
|-
| [https://medical-dictionary.thefreedictionary.com/SaO2 SaO2 (%)]
| 95% - 100%
|}
 
Find it in Patient Profile wiki page: [[(Patient_Profile)_Demographics_%26_Status#Add_Arterial_Blood_Gases_.28ABG.29|[Demographics & Status]]], [[(Patient_Profile)_Patient_Summary#PaO2.2FFiO2_chart|[Monitoring Charts]]], [[(Patient_Profile)_EHR_-_Daily_Monitoring#Arterial_Blood_Gas_.28ABG.29|[Daily Monitoring]]]
 
== Laboratory Information System (LIS)==
[https://medical-dictionary.thefreedictionary.com/laboratory+information+system Definition]
 
<span id="Infection-relatedIndices&CoagulationFunction"> </span>
{| class="wikitable"
|+Laboratory Information System
! style="text-align: center; background-color:#efefef;" | Process
! style="text-align: center; background-color:#efefef;" | Type
! style="text-align: center; background-color:#efefef;" | Ranges
|-
| rowspan="4" style="text-align: center;" | Infection-related Indices
| [https://medical-dictionary.thefreedictionary.com/hs-CRP hs-CRP (mg/L)]
| 0-5 (mg/L)
|-
| [https://medical-dictionary.thefreedictionary.com/IL-6 IL-6 (pg/L)]
| 0-7 (pg/L)
|-
| [https://medical-dictionary.thefreedictionary.com/ESR ESR (mm/h)]
| 0-15 (mm/h)
|-
| [https://medical-dictionary.thefreedictionary.com/Serum+ferritin Serum ferritin (ng/mL)]
| 21.8-274.66 (ng/mL)
|-
| rowspan="3" | Coagulation Function
| [https://medical-dictionary.thefreedictionary.com/Prothrombin+time PT (s)]
| 10.5-13.5 (s)
|-
| [https://www.thefreedictionary.com/activated%20partial%20thromboplastin%20time APTT (s)]
| 21-37 (s)
|-
| [https://medical-dictionary.thefreedictionary.com/D-dimer D-dimer (μg/mL)]
| 0-1.5 (μg/mL)
|}
 
<span id="Hematologic&Biochemical"> </span>
{| class="wikitable"
! style="font-weight:bold; background-color:#dae8fc;" | Process
! style="font-weight:bold; background-color:#dae8fc;" | Type
! style="font-weight:bold; background-color:#dae8fc;" | Ranges
|-
| rowspan="8" | Hematologic
| White blood cells (x10<sup>9</sup>/mL)
| 3.5-9.5 (x10<sup>9</sup>/mL)
|-
| Neutrophils (x10<sup>9</sup>/mL)
| 1.8-6.3 (x10<sup>9</sup>/mL)
|-
| Lymphocytes (x10<sup>9</sup>/mL)
| 1.1-3.2 (x10<sup>9</sup>/mL)
|-
| Monocytes (x10<sup>9</sup>/mL)
| 0.1-0.6 (x10<sup>9</sup>/mL)
|-
| Platelets (x10<sup>9</sup>/mL)
| 125-350 (x10<sup>9</sup>/mL)
|-
| CD3 (/μL)
| NA
|-
| CD4 (/μL)
| NA
|-
| CD8 (/μL)
| NA
|-
| rowspan="16" | Biochemical
| Total bilirubin (mg/dL)
| 0-26 (mg/dL)
|-
| AST (U/L)
| 15-40 (U/L)
|-
| ALT (U/L)
| 9-50 (U/L)
|-
| Total protein (g/L)
| 65-85 (g/L)
|-
| Albumin (g/L)
| 40-55 (g/L)
|-
| Globulin (g/L)
| 20-40 (g/L)
|-
| Prealbumin (mg/L)
| 200-430 (mg/L)
|-
| Urea (mM)
| 3.6-9.5 (mM)
|-
| Creatinine (μM)
| 57-111 (μM)
|-
| Glucose (mM)
| 3.9-6.1 (mM)
|-
| CK-MB (U/L)
| 0-24 (U/L)
|-
| Cholinesterase (U/L)
| 5000-12000 (U/L)
|-
| Cystatin C (mg/L)
| 0.6-1.55 (mg/L)
|-
| LDH (U/L)
| 120-150 (U/L)
|-
| α-HBDH (U/L)
| 72-182 (U/L)
|-
| LDL (mM)
| 2.1-3.37 (mM)
|}
 
Find it in Patient Profile wiki page: [[(Patient_Profile)_EHR_-_Daily_Monitoring#Infection-related_Indices|[Daily Monitoring]]], [[(Patient_Profile)_EHR_-_Laboratory|[Laboratory]]]
 
= Disease Severity Indicators=
==Acute Respiratory Distress Syndrome (ARDS) Severity==
[https://medical-dictionary.thefreedictionary.com/ARDS  Definition]
 
The [https://medical-dictionary.thefreedictionary.com/ARDS  Acute Respiratory Distress Syndrom (ARDS)] severity levels are calculated using the Berlin Definition as follows:
*ARDS
:- '''Mild ARDS:''' 200mmHg < [[Terminology#Arterial Blood Gases (ABG)|PaO2]]/[[Terminology#FiO2|FiO2]] ≤ 300 mmHg && (PEEP or [[Terminology#CPAP|CPAP]] ≥ 5 cmH2O) or non-ventilated.
 
:- '''Moderate ARDS:''' 100mmHg < [[Terminology#Arterial Blood Gases (ABG)|PaO2]]/[[Terminology#FiO2|FiO2]] ≤ 200 mmHg && PEEP ≥ 5 cmH2O or non-ventilated.
 
:- '''Severe  ARDS:''' [[Terminology#Arterial Blood Gases (ABG)|PaO2]]/[[Terminology#FiO2|FiO2]] ≤ 100 mmHg && PEEP ≥ 5 cmH2O or non-ventilated.
*'''ARDS''' when PaO2 not available.
:- [[Terminology#SpO2|SpO2]]/[[Terminology#FiO2|FiO2]] ≤ 315 suggests ARDS (including non-ventilated patients)
 
{| class="wikitable"
! colspan="5" style="background-color:#dae8fc;" | Berlin Definition of ARDS
|-
| colspan="2" style="background-color:#ecf4ff;" | ARDS Severity
| colspan="3" style="background-color:#ecf4ff;" | PaO2/FiO2
|-
| colspan="2" | Mild
| colspan="3" | >200-300
|-
| colspan="2" | Moderate
| colspan="3" | >100 - 200
|-
| colspan="2" | Severe
| colspan="3" | ≤100
|-
| colspan="5" | *on positive end expiratory pressure (PEEP) ≥ 5 cm H2O
|}
 
Find it in Patient Profile wiki page: [[(Patient_Profile)_Demographics_%26_Status#ARDS_-_Mews_-_Glasgow|[Demographics & Status]]]
 
==Modified Early Waring System (MEWS) Score ==
[https://medical-dictionary.thefreedictionary.com/MEWS Definition]
 
To calculate the [https://medical-dictionary.thefreedictionary.com/MEWS Modified Early Warning System (Mews)] score, we rank each one of values of the entries listed in the first column of Table Mews Calculation, based on where they fall in pre-defined ranges and then we sum-up all the ranks.
 
{| class="wikitable"
! style="font-weight:bold; background-color:#dae8fc;" | MEWS Score Range
! style="font-weight:bold; background-color:#dae8fc;" | Frequency of monitoring
! style="text-align: left; font-weight:bold; background-color:#dae8fc;" | Clinical Response
|-
| style="text-align: center; font-weight:bold;" | 0-4
| Minimum 12 hours
| Continue to monitor and review MEWS every 12 hours
|-
| style="text-align: center; font-weight:bold; background-color:#ecf4ff;" | 5-6
| style="background-color:#ecf4ff;" | Minimum 4 hours
| style="background-color:#ecf4ff;" | Consider notifying physician of MEWS score Notify charge nurse
Consider placing a consult to Rapid Response Nurses
 
Increase MEWS assessment every 4 hours with increased frequency in assessments
|-
| style="text-align: center; font-weight:bold;" | 7+
| Maximum per 2 hours
| Consider calling Physician with current assessment data
Consider calling a Rapid Response
Call RRT Consult nurse
Consider transferring to step-down or ICU
|}
 
 
 
{| class="wikitable"
! colspan="3" style="text-align: center; font-weight:bold; background-color:#dae8fc;" | Modified Early Warning System (MEWS)
|-
| style="font-weight:bold;" | Feature
| style="font-weight:bold;" | Value Range
| style="font-weight:bold;" | Score
|-
| rowspan="5" style="font-weight:bold; background-color:#ecf4ff;" | Respiratory Rate (bpm)
| style="text-align: center; background-color:#ecf4ff;" | ≤8
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| style="text-align: center; background-color:#ecf4ff;" | 9 - 14
| style="text-align: center; background-color:#ecf4ff;" | 0
|-
| style="text-align: center; background-color:#ecf4ff;" | 15 - 20
| style="text-align: center; background-color:#ecf4ff;" | 1
|-
| style="text-align: center; background-color:#ecf4ff;" | 21 - 29
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| style="text-align: center; background-color:#ecf4ff;" | >29
| style="text-align: center; background-color:#ecf4ff;" | 3
|-
| rowspan="6" style="font-weight:bold;" | Heart Rate (bpm)
| style="text-align: center;" | ≤ 40
| style="text-align: center;" | 2
|-
| style="text-align: center;" | 41 - 50
| style="text-align: center;" | 1
|-
| style="text-align: center;" | 51 - 100
| style="text-align: center;" | 0
|-
| style="text-align: center;" | 101 - 110
| style="text-align: center;" | 1
|-
| style="text-align: center;" | 111 - 129
| style="text-align: center;" | 2
|-
| style="text-align: center;" | > 129
| style="text-align: center;" | 3
|-
| rowspan="5" style="font-weight:bold; background-color:#ecf4ff;" | Systolic BP (mmHg)
| style="text-align: center; background-color:#ecf4ff;" | ≤ 70
| style="text-align: center; background-color:#ecf4ff;" | 3
|-
| style="text-align: center; background-color:#ecf4ff;" | 71 - 80
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| style="text-align: center; background-color:#ecf4ff;" | 81 - 100
| style="text-align: center; background-color:#ecf4ff;" | 1
|-
| style="text-align: center; background-color:#ecf4ff;" | 101 - 199
| style="text-align: center; background-color:#ecf4ff;" | 0
|-
| style="text-align: center; background-color:#ecf4ff;" | ≥ 200
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| rowspan="2" style="font-weight:bold;" | Urine Output (ml/kg/h)
| style="text-align: center;" | Nil
| style="text-align: center;" | 3
|-
| style="text-align: center;" | < 0.5
| style="text-align: center;" | 2
|-
| rowspan="5" style="font-weight:bold; background-color:#ecf4ff;" | Temperature (ºC)
| style="text-align: center; background-color:#ecf4ff;" | ≤ 35
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| style="text-align: center; background-color:#ecf4ff;" | 35.1 - 36
| style="text-align: center; background-color:#ecf4ff;" | 1
|-
| style="text-align: center; background-color:#ecf4ff;" | 36.1 - 38
| style="text-align: center; background-color:#ecf4ff;" | 0
|-
| style="text-align: center; background-color:#ecf4ff;" | 38.1 - 38.5
| style="text-align: center; background-color:#ecf4ff;" | 1
|-
| style="text-align: center; background-color:#ecf4ff;" | ≥ 38.6
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| colspan="2" style="text-align: center; font-weight:bold;" | Total:
| style="text-align: center;" |
|}
 
'''Important Assumptions: <span style="color:#FF0000> <br>1. When Urine Output is not inserted (i.e., NULL value), then the MEWS score is still computed assigning zero (0) points to Urine Output. <br>2. To compute the Urine Output per hour we calculate the time difference between the present Urine Output entry and the last non-NULL entry.</span>'''
 
Find it in Patient Profile wiki page: [[(Patient_Profile)_Demographics_%26_Status|[Demographics & Status]]], [[(Patient_Profile)_EHR_-_Daily_Monitoring#Vital_Signs|[Daily Monitoring]]]
 
== Glasgow Coma Scale Score==
[https://en.wikipedia.org/wiki/Glasgow_Coma_Scale Definition]
 
To calculate the [https://en.wikipedia.org/wiki/Glasgow_Coma_Scale Glasgow Coma Scale] score, we rank each one of values of the entries listed in the first column of Table Gasgow Calculation, based on where they fall in pre-defined ranges and then we sum-up all the ranks.
 
{| class="wikitable"
! colspan="3" style="text-align: center; font-weight:bold; background-color:#f8a102;" | Glasgow Coma Scale
|-
| style="text-align: center; font-weight:bold; background-color:#ffffff;" | Behavior
| style="text-align: center; font-weight:bold; background-color:#ffffff;" | Response
| style="text-align: center; font-weight:bold; background-color:#ffffff;" | Score
|-
| rowspan="4" style="text-align: center; font-weight:bold; background-color:#ecf4ff;" | Eye opening
| style="background-color:#ecf4ff;" | Spontaneous
| style="text-align: center; background-color:#ecf4ff;" | 4
|-
| style="background-color:#ecf4ff;" | To speech
| style="text-align: center; background-color:#ecf4ff;" | 3
|-
| style="background-color:#ecf4ff;" | To pain
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| style="background-color:#ecf4ff;" | None
| style="text-align: center; background-color:#ecf4ff;" | 1
|-
| rowspan="5" style="text-align: center; font-weight:bold; background-color:#ffffff;" | Verbal response
| style="background-color:#ffffff;" | Oriented
| style="text-align: center; background-color:#ffffff;" | 5
|-
| style="background-color:#ffffff;" | Confused
| style="text-align: center; background-color:#ffffff;" | 4
|-
| style="background-color:#ffffff;" | Words (Inappropriate)
| style="text-align: center; background-color:#ffffff;" | 3
|-
| style="background-color:#ffffff;" | Sounds (Incomprehensible)
| style="text-align: center; background-color:#ffffff;" | 2
|-
| style="background-color:#ffffff;" | None
| style="text-align: center; background-color:#ffffff;" | 1
|-
| rowspan="6" style="text-align: center; font-weight:bold; background-color:#ecf4ff;" | Motor response
| style="background-color:#ecf4ff;" | Obeys commands
| style="text-align: center; background-color:#ecf4ff;" | 6
|-
| style="background-color:#ecf4ff;" | Localizes to pain
| style="text-align: center; background-color:#ecf4ff;" | 5
|-
| style="background-color:#ecf4ff;" | Withdraws from pain
| style="text-align: center; background-color:#ecf4ff;" | 4
|-
| style="background-color:#ecf4ff;" | Flexion to pain (decorticate)
| style="text-align: center; background-color:#ecf4ff;" | 3
|-
| style="background-color:#ecf4ff;" | Extension to pain (decerebrate)
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| style="background-color:#ecf4ff;" | None
| style="text-align: center; background-color:#ecf4ff;" | 1
|-
| colspan="2" style="text-align: center; font-weight:bold; background-color:#f8a102;" | Assessment
| style="text-align: center; background-color:#f8a102;" | /15
|-
| rowspan="3" style="font-weight:bold; background-color:#ffffff;" | Total Score
| style="font-weight:bold; background-color:#ffffff;" | Mild
| style="text-align: center; background-color:#ffffff;" | 13-15
|-
| style="font-weight:bold; background-color:#ffffff;" | Moderate
| style="text-align: center; background-color:#ffffff;" | 9-12
|-
| style="font-weight:bold; background-color:#ffffff;" | Severe
| style="text-align: center; background-color:#ffffff;" | 8 or less
|}
Find it in Patient Profile wiki page: [[(Patient_Profile)_Demographics_%26_Status|[Demographics & Status]]], [[(Patient_Profile)_EHR_-_Daily_Monitoring#Glasgow_Coma_Scale_Measures|[Daily Monitoring]]]
 
== Hscore==
[http://saintantoine.aphp.fr/score/ Definition]
 
The [http://saintantoine.aphp.fr/score/ Hscore] generates a probability for the presence of secondary [https://encyclopedia.thefreedictionary.com/Hemophagocytic+lymphohistiocytosis haemophagocytic lymphohistiocytosis (HLH)]<sup>1</sup>.
*Hscores greater that 169 are 93% sensitive and 86% specific for HLH.
 
*Hscores can be calculated using the [http://saintantoine.aphp.fr/score/ online calculator].
Note that bone marrow haemophagocytosis is not mandatory for a diagnosis of HLH.<sup>2</sup>
 
{| class="wikitable"
! colspan="2" style="text-align: center; font-weight:bold; background-color:#dae8fc;" | Hscore
|-
| style="background-color:#ecf4ff;" | Temperature
| style="text-align: right; font-weight:bold; background-color:#ecf4ff;" |
|-
| <38.4
| style="text-align: right; font-weight:bold;" | 0
|-
| 38.4-39.4
| style="text-align: right; font-weight:bold;" | 33
|-
| >39.4
| style="text-align: right; font-weight:bold;" | 49
|-
| style="background-color:#ecf4ff;" | Organomegaly
| style="text-align: right; font-weight:bold; background-color:#ecf4ff;" |
|-
| None
| style="text-align: right; font-weight:bold;" | 0
|-
| Hepatomegaly or splenomegaly
| style="text-align: right; font-weight:bold;" | 23
|-
| Hepatomegaly and splenomegaly
| style="text-align: right; font-weight:bold;" | 38
|-
| style="background-color:#ecf4ff;" | Number of cytopenias
| style="text-align: right; font-weight:bold; background-color:#ecf4ff;" |
|-
| One lineage
| style="text-align: right; font-weight:bold;" | 0
|-
| Two lineages
| style="text-align: right; font-weight:bold;" | 24
|-
| Three lineages
| style="text-align: right; font-weight:bold;" | 34
|-
| style="background-color:#ecf4ff;" | Triglycerides (mmoL/L)
| style="text-align: right; font-weight:bold; background-color:#ecf4ff;" |
|-
| <1.5 mmol/L
| style="text-align: right; font-weight:bold;" | 0
|-
| 1.5-4.0 mmol/L
| style="text-align: right; font-weight:bold;" | 44
|-
| >4 mmol/L
| style="text-align: right; font-weight:bold;" | 64
|-
| style="background-color:#ecf4ff;" | Fibrinogen (g/L)
| style="text-align: right; background-color:#ecf4ff;" |
|-
| >2.5 g/L
| style="text-align: right; font-weight:bold;" | 0
|-
| <=2.5 g/L
| style="text-align: right; font-weight:bold;" | 30
|-
| style="background-color:#ecf4ff;" | Ferritin ng/ml
| style="text-align: right; font-weight:bold; background-color:#ecf4ff;" |
|-
| <2000 ng/ml
| style="text-align: right; font-weight:bold;" | 0
|-
| 2000-6000 ng/ml
| style="text-align: right; font-weight:bold;" | 35
|-
| >6000 ng/ml
| style="text-align: right; font-weight:bold;" | 50
|-
| style="background-color:#ecf4ff;" | Serum aspartate aminotransferase
| style="text-align: right; font-weight:bold; background-color:#ecf4ff;" |
|-
| <30 IU/L
| style="text-align: right; font-weight:bold;" | 0
|-
| >=30 IU/L
| style="text-align: right; font-weight:bold;" | 19
|-
| style="background-color:#ecf4ff;" | Haemophagocytosis on bone marrow aspirate
| style="text-align: right; font-weight:bold; background-color:#ecf4ff;" |
|-
| No
| style="text-align: right; font-weight:bold;" | 0
|-
| Yes
| style="text-align: right; font-weight:bold;" | 35
|-
| style="background-color:#ecf4ff;" | Known immunosuppression
| style="text-align: right; font-weight:bold; background-color:#ecf4ff;" |
|-
| No
| style="text-align: right; font-weight:bold;" | 0
|-
| Yes
| style="text-align: right; font-weight:bold;" | 18
|-
| style="font-weight:bold;" | Hscore
|
|}
 
[https://onlinelibrary.wiley.com/doi/full/10.1002/art.38690<sup>1</sup>Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., Coppo, P. and Hejblum, G., 2014. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis & Rheumatology, 66(9), pp.2613-2620.]
[https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext <br> <sup>2</sup>Mehta, P., McAuley, D.F., Brown, M., Sanchez, E., Tattersall, R.S. and Manson, J.J., 2020. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet.]


                                                         
==Ventricular Arrhythmia Risk==
| style="vertical-align:top;"|<table cellspacing=0 cellpadding=0><tr><td valign=top> Alcohol intake<br>Health-related behavior <br> Tobacco use and exposure <br> Exercise <br> Details of drug misuse behavior <br> Nutritional observable <br> Employment detail <br> Toxic exposure status</table>  
'''Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19<sup>1</sup>'''


{| class="wikitable"
! colspan="2" style="font-weight:bold; background-color:#dae8fc;" | Risk Score For Drug-Associated QTc Prolongation<sup>2</sup>
|-
| style="font-weight:bold; background-color:#dae8fc;" | Risk Factors
| style="text-align: center; font-weight:bold; background-color:#dae8fc;" | Points
|-
| Age  ≥ 68 years
| style="text-align: center;" | 1
|-
| style="background-color:#ecf4ff;" | Female Sex
| style="text-align: center; background-color:#ecf4ff;" | 1
|-
| Loop diuretic
| style="text-align: center;" | 1
|-
| style="background-color:#ecf4ff;" | Serum K+ ≤3.5 mEq/L
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| Admission QTc  ≥ 450 ms
| style="text-align: center;" | 2
|-
| style="background-color:#ecf4ff;" | Acute MI
| style="text-align: center; background-color:#ecf4ff;" | 2
|-
| ≥2 QTc-prolonging drugs
| style="text-align: center;" | 3
|-
| style="background-color:#ecf4ff;" | Sepsis
| style="text-align: center; background-color:#ecf4ff;" | 3
|-
| Heart failure
| style="text-align: center;" | 3
|-
| style="background-color:#ecf4ff;" | One QTc-prolonging drug
| style="text-align: center; background-color:#ecf4ff;" | 3
|-
| style="font-weight:bold;" | Maximum Risk Score
| style="text-align: center; font-weight:bold;" | 21
|-
| style="background-color:#ffffff;" | Low Risk
| style="background-color:#ffffff;" | ≤6 points
|-
| style="background-color:#ffffff;" | Moderate Risk
| style="background-color:#ffffff;" | 7-10 points
|-
| style="background-color:#ffffff;" | High Risk
| style="background-color:#ffffff;" | ≥11 points
|-
| K+ indicates potassium; and MI, myocardial infarction.
| style="text-align: center;" |
|}
|}
[https://www.acc.org/latest-in-cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to-hydroxychloroquine-azithromycin-treatment-for-covid-19 <sup>1</sup>Timothy F. Simpson, Richard J. Kovacs, and Eric C. Stecker, Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19, Cardiology Magazine, Mar. 29, 2020]
[https://www.ahajournals.org/doi/full/10.1161/circoutcomes.113.000152<sup>2</sup> Tisdale JE, Jayes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6:479-487.]

Revision as of 10:47, 20 April 2021

In this page all the terms used to describe the health in the Patient Profile screen are presented. Below each term in Ranges and Scores sections you can find links to the locations of the Patient Profile wiki page where the corresponding terms are used. By clicking these links you will be driven to the corresponding parameter's section in the Patient Profile page of this wiki.

Acronyms Finder

Vital Signs Social history
Temperature (°C)
Heart Rate (bpm)
Systolic Pressure (mm Hg)
Diastolic Pressure (mm Hg)
Respiratory Rate (bpm)
SpO2 (%)
pH
SpO2
Covid-19 Related
hs-CRP ((mg/L))
Alcohol intake
Health-related behavior
Tobacco use and exposure
Exercise
Details of drug misuse behavior
Nutritional observable
Employment detail
Toxic exposure status


Comorbidities Symptoms Ventilation Treatment
Hypertension
Diabetes
Cardiovascular disease
Liver disease
Nervous system disease
Chronic respiratory/ lung disease
Chronic kidney disease
Endocrine system disease
Hematologic disease
Tumor
Immunosuppression
Immunodeficiency
Constitutional
Fever
Myalgia
Headache
Upper Respiratory
Rhinorrhea
Nasal Congestion
Sore throat
Lower Respiratory
Dyspnea
Chest tightness
Cough
Sputum
Gastrointestinal
Nausea
Diarrhea
Neurological
Ageusia
Anosmia
Communication disorder
Acquired Confusion
Lethargy

Ranges

Vital Signs

Definition

Vital Signs
Type Ranges
Temperature (°C) 36.1 -37.2 (°C)
Heart Rate (bpm) 60-100 (bpm)
Systolic Pressure (mm Hg) 90-140 (mm Hg)
Diastolic Pressure (mm Hg) 75-90 (mm Hg)
Respiratory Rate (bpm) 16-20 (bpm)
SpO2 (%) >93%
Urine Output (ml/kg/h) Based on Fluid Balance (Intake/ Output)
Find it in Patient Profile wiki page: [Demographics & Status], [Monitoring Charts], [Daily Monitoring]

Arterial Blood Gases (ABG)

Definition

An arterial blood gases (ABG) test measures the acidity (pH) and the levels of oxygen and carbon dioxide in the blood from an artery. This test is used to check how well your lungs are able to move oxygen into the blood and remove carbon dioxide from the blood.

Arterial Blood Gases
Type Ranges
pH 7.35 - 7.45
HCO3 (mEq/L) 22 - 26 (mEq/L)
PaCO2(mmHg) 35 - 45 (mmHg)
PaO2 (mmHg) 75 - 100 (mmHg)
SaO2 (%) 95% - 100%
Find it in Patient Profile wiki page: [Demographics & Status], [Monitoring Charts], [Daily Monitoring]

Laboratory Information System (LIS)

Definition

Laboratory Information System
Process Type Ranges
Infection-related Indices hs-CRP (mg/L) 0-5 (mg/L)
IL-6 (pg/L) 0-7 (pg/L)
ESR (mm/h) 0-15 (mm/h)
Serum ferritin (ng/mL) 21.8-274.66 (ng/mL)
Coagulation Function PT (s) 10.5-13.5 (s)
APTT (s) 21-37 (s)
D-dimer (μg/mL) 0-1.5 (μg/mL)

Process Type Ranges
Hematologic White blood cells (x109/mL) 3.5-9.5 (x109/mL)
Neutrophils (x109/mL) 1.8-6.3 (x109/mL)
Lymphocytes (x109/mL) 1.1-3.2 (x109/mL)
Monocytes (x109/mL) 0.1-0.6 (x109/mL)
Platelets (x109/mL) 125-350 (x109/mL)
CD3 (/μL) NA
CD4 (/μL) NA
CD8 (/μL) NA
Biochemical Total bilirubin (mg/dL) 0-26 (mg/dL)
AST (U/L) 15-40 (U/L)
ALT (U/L) 9-50 (U/L)
Total protein (g/L) 65-85 (g/L)
Albumin (g/L) 40-55 (g/L)
Globulin (g/L) 20-40 (g/L)
Prealbumin (mg/L) 200-430 (mg/L)
Urea (mM) 3.6-9.5 (mM)
Creatinine (μM) 57-111 (μM)
Glucose (mM) 3.9-6.1 (mM)
CK-MB (U/L) 0-24 (U/L)
Cholinesterase (U/L) 5000-12000 (U/L)
Cystatin C (mg/L) 0.6-1.55 (mg/L)
LDH (U/L) 120-150 (U/L)
α-HBDH (U/L) 72-182 (U/L)
LDL (mM) 2.1-3.37 (mM)
Find it in Patient Profile wiki page: [Daily Monitoring], [Laboratory]

Disease Severity Indicators

Acute Respiratory Distress Syndrome (ARDS) Severity

Definition

The Acute Respiratory Distress Syndrom (ARDS) severity levels are calculated using the Berlin Definition as follows:

  • ARDS
- Mild ARDS: 200mmHg < PaO2/FiO2 ≤ 300 mmHg && (PEEP or CPAP ≥ 5 cmH2O) or non-ventilated.
- Moderate ARDS: 100mmHg < PaO2/FiO2 ≤ 200 mmHg && PEEP ≥ 5 cmH2O or non-ventilated.
- Severe ARDS: PaO2/FiO2 ≤ 100 mmHg && PEEP ≥ 5 cmH2O or non-ventilated.
  • ARDS when PaO2 not available.
- SpO2/FiO2 ≤ 315 suggests ARDS (including non-ventilated patients)
Berlin Definition of ARDS
ARDS Severity PaO2/FiO2
Mild >200-300
Moderate >100 - 200
Severe ≤100
*on positive end expiratory pressure (PEEP) ≥ 5 cm H2O
Find it in Patient Profile wiki page: [Demographics & Status]

Modified Early Waring System (MEWS) Score

Definition

To calculate the Modified Early Warning System (Mews) score, we rank each one of values of the entries listed in the first column of Table Mews Calculation, based on where they fall in pre-defined ranges and then we sum-up all the ranks.

MEWS Score Range Frequency of monitoring Clinical Response
0-4 Minimum 12 hours Continue to monitor and review MEWS every 12 hours
5-6 Minimum 4 hours Consider notifying physician of MEWS score Notify charge nurse

Consider placing a consult to Rapid Response Nurses

Increase MEWS assessment every 4 hours with increased frequency in assessments

7+ Maximum per 2 hours Consider calling Physician with current assessment data

Consider calling a Rapid Response Call RRT Consult nurse Consider transferring to step-down or ICU


Modified Early Warning System (MEWS)
Feature Value Range Score
Respiratory Rate (bpm) ≤8 2
9 - 14 0
15 - 20 1
21 - 29 2
>29 3
Heart Rate (bpm) ≤ 40 2
41 - 50 1
51 - 100 0
101 - 110 1
111 - 129 2
> 129 3
Systolic BP (mmHg) ≤ 70 3
71 - 80 2
81 - 100 1
101 - 199 0
≥ 200 2
Urine Output (ml/kg/h) Nil 3
< 0.5 2
Temperature (ºC) ≤ 35 2
35.1 - 36 1
36.1 - 38 0
38.1 - 38.5 1
≥ 38.6 2
Total:
Important Assumptions:  
1. When Urine Output is not inserted (i.e., NULL value), then the MEWS score is still computed assigning zero (0) points to Urine Output.
2. To compute the Urine Output per hour we calculate the time difference between the present Urine Output entry and the last non-NULL entry.
Find it in Patient Profile wiki page: [Demographics & Status], [Daily Monitoring]

Glasgow Coma Scale Score

Definition

To calculate the Glasgow Coma Scale score, we rank each one of values of the entries listed in the first column of Table Gasgow Calculation, based on where they fall in pre-defined ranges and then we sum-up all the ranks.

Glasgow Coma Scale
Behavior Response Score
Eye opening Spontaneous 4
To speech 3
To pain 2
None 1
Verbal response Oriented 5
Confused 4
Words (Inappropriate) 3
Sounds (Incomprehensible) 2
None 1
Motor response Obeys commands 6
Localizes to pain 5
Withdraws from pain 4
Flexion to pain (decorticate) 3
Extension to pain (decerebrate) 2
None 1
Assessment /15
Total Score Mild 13-15
Moderate 9-12
Severe 8 or less
Find it in Patient Profile wiki page: [Demographics & Status], [Daily Monitoring]

Hscore

Definition

The Hscore generates a probability for the presence of secondary haemophagocytic lymphohistiocytosis (HLH)1.

  • Hscores greater that 169 are 93% sensitive and 86% specific for HLH.

Note that bone marrow haemophagocytosis is not mandatory for a diagnosis of HLH.2

Hscore
Temperature
<38.4 0
38.4-39.4 33
>39.4 49
Organomegaly
None 0
Hepatomegaly or splenomegaly 23
Hepatomegaly and splenomegaly 38
Number of cytopenias
One lineage 0
Two lineages 24
Three lineages 34
Triglycerides (mmoL/L)
<1.5 mmol/L 0
1.5-4.0 mmol/L 44
>4 mmol/L 64
Fibrinogen (g/L)
>2.5 g/L 0
<=2.5 g/L 30
Ferritin ng/ml
<2000 ng/ml 0
2000-6000 ng/ml 35
>6000 ng/ml 50
Serum aspartate aminotransferase
<30 IU/L 0
>=30 IU/L 19
Haemophagocytosis on bone marrow aspirate
No 0
Yes 35
Known immunosuppression
No 0
Yes 18
Hscore

1Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., Coppo, P. and Hejblum, G., 2014. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis & Rheumatology, 66(9), pp.2613-2620.
2Mehta, P., McAuley, D.F., Brown, M., Sanchez, E., Tattersall, R.S. and Manson, J.J., 2020. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet.

Ventricular Arrhythmia Risk

Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-191

Risk Score For Drug-Associated QTc Prolongation2
Risk Factors Points
Age ≥ 68 years 1
Female Sex 1
Loop diuretic 1
Serum K+ ≤3.5 mEq/L 2
Admission QTc ≥ 450 ms 2
Acute MI 2
≥2 QTc-prolonging drugs 3
Sepsis 3
Heart failure 3
One QTc-prolonging drug 3
Maximum Risk Score 21
Low Risk ≤6 points
Moderate Risk 7-10 points
High Risk ≥11 points
K+ indicates potassium; and MI, myocardial infarction.

1Timothy F. Simpson, Richard J. Kovacs, and Eric C. Stecker, Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19, Cardiology Magazine, Mar. 29, 2020

2 Tisdale JE, Jayes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6:479-487.